Stock-based Compensation (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 15, 2024 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Stock options granted | 0 | 0 | 0 | |||
| Stock options excercised | 0 | |||||
| Stock-based compensation expense | $ 3,000 | $ 8,000 | $ 25,000 | $ 511,000 | ||
| Fair value of common stock, granted | $ 49.99 | |||||
| Eos SENOLYTIXS Inc [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Stock-based compensation expense | $ 7,455 | $ 86 | $ 10 | $ 345 | ||
| Purchase of options granted shares | 23,529 | 41,175 | ||||
| Number of options vested | 129,412 | 505,000 | 505,000 | |||
| Options vested term | 4 years | |||||
| Share based compensation description | Upon the closing of either a Qualified Financing or Validating event, 25% of the grants will vest immediately and the remaining shares will vest ratably over the following 36 months. No compensation expense related to these options was recognized during the three months ended March 31, 2026 or 2025 because the performance condition was not considered probable of achievement as of March 31, 2026 or March 31, 2025. The remaining 23,529 options granted during the three months ended March 31, 2025 will vest over a period of four years | Upon the closing of either a Qualified Financing or Validating event, 25% of the grants will vest immediately and the remaining shares will vest ratably over the following 36 months. No compensation expense related to these options was recognized during the year ended December 31, 2025 as the closing of either event was not considered probable for accounting purposes as of December 31, 2025. Of the remaining 41,175 options granted during the year ended December 31, 2025, 23,529 options will vest over four years, and 17,646 options will vest over twelve months. Vesting for the 17,646 options will be accelerated if the Company closes on certain transactions valued at $5 million (50% vesting) and $10 million (100% vesting). | ||||
| Unrecognized stock-based compensation expense | $ 520,352 | $ 1,368 | $ 6,410 | |||
| Remaining weighted-average vesting period | 2 years 6 months | 4 years | 2 years 1 month 6 days | |||
| Options strike price | $ 0.01 | $ 0.01 | ||||
| Options vested | 35,292 | |||||
| Options vested term | 4 years | 4 years | ||||
| Weighted average grant-date fair value of options, granted | $ 3.17 | $ 0.01 | ||||
| Fair value of common stock, granted | $ 0.01 | |||||
| Eos SENOLYTIXS Inc [Member] | Share-Based Payment Arrangement, Option [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Stock options granted | 164,704 | 137,815 | 546,175 | |||
| Stock options excercised | ||||||
| Number of options vested | 848,694 | 683,990 | ||||
| Vested and expected to vest, exercisable | $ 0.72 | $ 0.01 | $ 0.01 | $ 0.01 | ||
| Options vested term | 9 years 25 days | 9 years 1 month 20 days | ||||
| Options exercise price | $ 17.00 | $ 0.01 | ||||
| Fair value of common stock, granted | $ 0.01 | $ 0.01 | ||||
| Eos SENOLYTIXS Inc [Member] | Share-Based Payment Arrangement, Tranche One [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Number of options vested | 23,529 | |||||
| Vesting period | 4 years | 4 years | ||||
| Eos SENOLYTIXS Inc [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Number of options vested | 17,646 | |||||
| Vesting period | 12 months | |||||
| Options vested accelerated | 17,646 | |||||
| Eos SENOLYTIXS Inc [Member] | Employees, Directors and Consultants [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Stock-based compensation expense | $ 7,455 | $ 86 | $ 10 | $ 345 | ||
| Purchase of options granted shares | 164,704 | 528,529 | 137,815 | 546,175 | ||
| Share granted fair value | $ 521,322 | $ 5,285 | $ 1,378 | $ 5,462 | ||
| 2024 Equity Incentive Plan [Member] | Eos SENOLYTIXS Inc [Member] | ||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
| Total number of securities reserved for issuance | 882,353 | |||||
| X | ||||||||||
- Definition Common stock capital shares reserved. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options vested and expected to vest outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested option for which requisite service period has not been rendered but that is expected to vest based on achievement of performance condition, if forfeiture is recognized when it occurs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|